N-acetylcysteine decreases dopamine transporter availability in the non-lesioned striatum of the 6-OHDA hemiparkinsonian ratVisa övriga samt affilieringar
2022 (Engelska)Ingår i: Neuroscience Letters, ISSN 0304-3940, E-ISSN 1872-7972, Vol. 770, artikel-id 136420Artikel i tidskrift (Refereegranskat) Published
Abstract [en]
This study aimed to explore the beneficial effects of the antioxidant N-acetylcysteine (NAC) on the degenerated dopamine system. The short- and long-term regulatory mechanisms of NAC on the 6-OHDA hemiparkinsonian rat model were longitudinally investigated by performing positron emission tomography (PET) imaging using the specific dopamine transporter (DAT) radioligand [18F]FE-PE2I. The results demonstrate that after a unilateral dopamine insult NAC has a strong influence on the non-lesioned hemisphere by decreasing the levels of DAT in the striatum early after the lesion. We interpret this early and short-term decrease of DAT in the healthy striatum of NAC-treated animals as a beneficial compensatory effect induced by NAC.
Ort, förlag, år, upplaga, sidor
Elsevier, 2022. Vol. 770, artikel-id 136420
Nyckelord [en]
6-OHDA, N-acetylcysteine, Neuroimaging, Parkinson's disease, PET
Nationell ämneskategori
Neurovetenskaper
Identifikatorer
URN: urn:nbn:se:umu:diva-191188DOI: 10.1016/j.neulet.2021.136420ISI: 000742672900005Scopus ID: 2-s2.0-85122253129OAI: oai:DiVA.org:umu-191188DiVA, id: diva2:1626334
Forskningsfinansiär
Region VästerbottenStiftelsen Lars Hiertas Minne2022-01-112022-01-112023-09-05Bibliografiskt granskad